NOSOLOGICAL STRUCTURE AND DERMATOSCOPIC PECULIARITIES OF SKIN NEOPLASMS IN MEDICAL STUDENTS. RISK FACTORS FOR DEVELOPMENT OF MALIGNANT TRANSFORMATIONS ASSESSED BY SURVEY DATA

Abstract

Aim. To determine the nosological clinical and dermatoscopic structure of benign neoplasms of the skin with assessment of risk factors for malignant transformation. Materials and methods. Clinical and dermatoscopic examination of 50 medical students (mean age 23,5 ± 3,1) was conducted. To assess risk factors for nevus malignization, a questionnaire, consisting of 5 parts was developed. Clinical examination included visual examination of skin and dermatoscopy of the detected elements with their quantitative calculation, estimation of pigment distribution and determination of nevus structure. Results. A high level of affection with skin neoplasms was detected in young persons; benign tumors of melanogenic nature (100 %) and epidermal tumors (64,0 %) prevailed. Safe from the point of view of malignization nevuses, including boundary (40,0 %) and dermal (56,0 %), were characterized by benign signs of dermatoscopic picture. Conclusions. The risk group, requiring dynamic clinical and dermatoscopic follow-up, included students with multiple nevuses (20,0 %) and dermatoscopic signs of active changes in them (14,0 %), as well as those with multiple sun lentigo (41,2 %), localized on the skin of the upper shoulder girdle (52,9 %).

Keywords

Melanoma / melanocytic nevuses / skin neoplasms / dermatoscopy / risk factors

References

[1] Акимов В.Г. Фотодерматозы. Кожные и венерические болезни: руководство для врачей: в 4 т. Т. 2. Под ред. Ю.К. Скрипкина. М.: Медицина 1995; 341-365.

[2] Белова Н.И., Туманян А.Г. Опыт работы кабинета дерматоонкологии. Альманах клинической медицины 2006; 9: 23-25.

[3] Демидов Л.В., Харкевич Г.Ю. Меланома кожи: стадирование, диагностика и лечение. Российский медицинский журнал 2003; 11: 658.

[4] Злокачественные новообразования в России в 2015 году (заболеваемость и смертность). Под ред. О.В. Каприна, В.В. Старинского, Г.В. Петровой; МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИРЦ» Минздрава России. М. 2016; 250.

[5] Ламоткин И.А. Меланиновые и меланоцитарные поражения кожи. М.: Бином 2011; 248.

[6] Мурашко Р.А., Горяинова А.Ю., Тесленко Л.Г., Шаров С.В., Шатохина А.С. Диссеминированная меланома кожи: актуальность проблемы, распространенность, перспективы лекарственного обеспечения. Инновационная медицина Кубани 2016; 4: 46-47.

[7] Онкология: учебник с компакт-диском. Под ред. В.И. Чиссова, С.Л. Дарьяловой. М.: ГЭОТАР-Медиа 2007; 560.

[8] Орлов О.А. Клинико-эпидемиологические особенности меланомы кожи в крупном промышленном городе (г. Пермь). Family health in the XXI century: материалы междунар. науч. конф. Гоа, Индия 2004; 226-229.

[9] Статистика злокачественных новообразований в России и странах СНГ в 2009 г. Под ред. М.И. Давыдова, Е.М. Аксель. Вестник РОНЦ им. Н.Н. Блохина РАМН. 2011; 22 (85), приложение 1.

[10] Шляхтунов Е.А., Гидранович А.В., Луд Н.Г., Луд Л.Н., Кожар В.Л., Прокшин А.В. Рак кожи: современное состояние проблемы. Вестник ВГМУ 2014; 3: 20-28.

[11] Austin D., Reynolds P. Occupation and malignant melanoma. Epidemiology of malignant melanoma. Berlin 1986; 98-107.

[12] Boniol M., Autier P., Boyle P., Gandini S. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. BMJ 2012: 47-57.

[13] Bourne P. BLINCK - a diagnostic algorithm for skin cancer diagnosis combining clinical features with dermatoscopy findings. Dermatol Pract Concept 2012; 2 (2): 12.

[14] Demierre M.F. Time for the national legislation of indoor tanning to protect minors. Arch Dermatol 2003; 139: 20-524.

[15] Fitzpatrick T. The validity and practicality of sun-reactive skin types I through VI. Arch Derm 1988; 124: 869-871.

[16] Gandini S., Sera F., Cattaruzza M.S., Pasquini P., Picconi O., Boyle P. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005; 41: 45-60.

[17] Garbe C. Diagnosis and treatment of melanoma: European consensus-based disciplinary guideline. Eur J Cancer 2010; 46: 270-283.

[18] Koomen E.R., Joosse A., Herings R.M., Casparie M.K., Guchelaar H.J., Nijsten T. Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study. Ann Oncol 2009; 20: 358-364.

[19] Lazovich D., Vogel R.I., Berwick M., Weinstock M.A., Anderson K.E., Warshaw E.M. Indoor tanning and risk of melanoma: a case-control study in a highly-exposed population. Cancer Epidem Biomar Prev 2010; 19 (6): 1557-1568.

[20] Levanat S., Gorlin R.J., Fallet S. A two-hit model for developmental defects in Gorlin syndrome. Nat Genet 1996; 12: 85-87.

[21] Markovic S.N. Malignant melanoma in the 21st Century. Part 1: Epidemiology, risk factors, screening, prevention and diagnosis. Mayo. Clin Proc 2007; 82: 364-380.

[22] Miller A.J., Mihm M.C. Jr. Melanoma. N Engl J Med 2006; 355: 51-65.

[23] National comprehensive cancer network. NCCN Clinical Practice Guidelines in Oncology TM Melanoma 2013; vol. 2.

[24] Pfahlberg A., Kolmel K.F., Gefeller O. Timing of excessive ultraviolet radiation and melanoma: epidemiology does not support the existence of a critical period of high susceptibility to solar ultraviolet radiation-induced melanoma. Brit J Dermatol 2001; 144 (3): 471.

[25] Rhodes A.R., Harrist T.J., Momtaz T.K. The PUVA-induced pigmented macule: a lentiginous proliferation of large, sometimes cytologically atypical, melanocytes. J Am Acad Dermatol 1983; 9: 47-58.

[26] Swerdlow A.J., Weinstock M.A. Do tanning lamps cause melanoma? An epidemiologic assessment. J Amer Acad Dermatol 1998; 38: 89-98.

[27] Wu S., Han J., Laden F., Qureshi A.A. Long-term ultraviolet flux, other potential risk factors, and skin cancer risk: a cohort study. Cancer Epidemiol Biomar Prev 2014; 23(6): 1080-1089.

RIGHTS & PERMISSIONS

Morozova A.D., Sedova T.G., Elkin V.D.